Gary Bridger, EVP, Research & Development at Xenon, holds 0.00 shares in Xenon (Ticker: XENE), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR), holds 0.00 shares in Neoleukin Therapeutics (Ticker: NLTX). Most recently, Gary Bridger ― shares of Xenon on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Gary Bridger?
The percentage of profitable transactions made by Gary Bridger is ―.
What is the average return per transaction made by Gary Bridger?
The average return per transaction made by Gary Bridger is ―.
What stocks does Gary Bridger hold?
Gary Bridger holds: XENE, XFOR, NLTX, ALDR stocks.
What was Gary Bridger’s latest transaction?
Gary Bridger latest transaction was an Uninformative Buy of ―.
What was Gary Bridger's most profitable transaction?
Gary Bridger’s most profitable transaction was an Informative Buy of ALDR stock on May 15, 2014. The return on the trade was 296.00%.
What is Gary Bridger's role in Xenon?
Gary Bridger's role in Xenon is EVP, Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.